It is used for the management of chronic COPD and it can be used as a rescue inhaler as well. It is available as a 45 mcg aerosol or a nebulizer (0.31 mg/3 mL, 0.63 mg/3 mL, 1.25 mg/3 mL, or 1.25 ...

Extrafine single inhaler triple therapy is effective among patients with COPD who were previously treated with multiple-inhaler triple therapy.

Patients with asthma and COPD routinely switch from pressurized metered-dose inhalers (pMDIs) to dry powder inhalers (DPIs) and vice versa.

The U.S. Food and Drug Administration has approved Dupixent (dupilumab) to reduce COPD exacerbations in some patients whose symptoms aren’t adequately controlled with inhaled medicines.

Poor treatment of asthma and COPD puts a huge burden on the NHS. For example, £1 billion is spent on asthma treatment in the UK each year and represents 60,000 to 65,000 hospital admissions. In ...

A new analysis that compares two common inhalers for patients suffering from chronic obstructive pulmonary disease (COPD) finds that one reduces respiratory-related hospitalizations and ...

Purpose: Pharmacokinetic and safety data related to the use of inhaled insulin for the management of diabetes mellitus are discussed. The various pulmonary insulin delivery systems under ...

Digital inhalers improve adherence but have not significantly impacted patient outcomes; affordability and education are crucial. Digital technologies effectively deliver pulmonary rehabilitation ...

Qualcomm and its rival Propeller are emerging as the tech companies to partner with in the development of smart inhalers. Virtually all the companies active in the asthma and COPD markets have ...

“We’re trying to treat conditions like asthma and COPD with these inhalers, and we’re actually making it harder to breathe,” said Jyothi Tirumalasetty, a clinical assistant professor at ...

Inhaler misuse leading to inadequate medication delivery impacts a person's ability to manage symptoms of chronic obstructive pulmonary disease (COPD), and additional education about proper ...